<code id='F9633BF286'></code><style id='F9633BF286'></style>
    • <acronym id='F9633BF286'></acronym>
      <center id='F9633BF286'><center id='F9633BF286'><tfoot id='F9633BF286'></tfoot></center><abbr id='F9633BF286'><dir id='F9633BF286'><tfoot id='F9633BF286'></tfoot><noframes id='F9633BF286'>

    • <optgroup id='F9633BF286'><strike id='F9633BF286'><sup id='F9633BF286'></sup></strike><code id='F9633BF286'></code></optgroup>
        1. <b id='F9633BF286'><label id='F9633BF286'><select id='F9633BF286'><dt id='F9633BF286'><span id='F9633BF286'></span></dt></select></label></b><u id='F9633BF286'></u>
          <i id='F9633BF286'><strike id='F9633BF286'><tt id='F9633BF286'><pre id='F9633BF286'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:5
          Hospital power in DC
          Mike Reddy for STAT

          WASHINGTON — Democrats unilaterally drove major reforms to the health insurance and the pharmaceutical industries without a single Republican vote in recent years. But hospitals may be a health care giant they’re unable to confront alone.

          Unlike Republicans, Democrats have seized on lowering health care costs as a politically winning issue in one election cycle after another. They have campaigned on passing health insurance reform, and then protecting it. And after 20 years, they finally delivered on a promise to empower the federal government to lower drug prices in 2022.

          advertisement

          But the remaining elephant in the room is hospital costs, which make up the biggest share of U.S. health care spending. And Democratic leaders in Congress have shown this year that they are unable to agree on even the most incremental steps toward addressing the cost of hospital care.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          U.K. not yet recommending Vertex's CRISPR therapy for sickle cell
          U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

          JOSEPHPREZIOSO/AFPviaGettyImagesLONDON—TheU.K.’scost-effectivenesswatchdogsaidThursdayitisnotyetreco

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

          AdobeTheFoodandDrugAdministrationsaidMondaythatithasdeepreservationsaboutNurOwn,aninvestigationalALS